Showing 6571-6580 of 7529 results for "".
- ISDIN Launches Melatonik Nighttime Serumhttps://practicaldermatology.com/news/isdin-launches-melatonik-nighttime-serum/2457577/ISDIN's Melatonik nighttime serum formulated with melatonin, bakuchiol (a natural antioxidant with retinol-like properties) and Vitamin C, is now available. It was developed to help skin recover from the day and prepare it to fi
- Recros Medica Unveils the Nuvellus Brand for Its Novel Rotational Fractional Resection Technologyhttps://practicaldermatology.com/news/recros-medica-unveils-the-nuvellus-brand-for-its-novel-rotational-fractional-resection-technology/2457588/Recros Medica, Inc. is unveiling the Nuvellus brand at this week’s American Society of Plastic Surgery meeting. The company will display at booth #1264, where it will introduce Nuvellus as an innovative, minimally-invasive surgical procedure in develop
- Bellus Medical Now Part of Crown Laboratorieshttps://practicaldermatology.com/news/bellus-medical-now-part-of-crown-laboratories/2457590/Crown Laboratories, Inc. and Hildred Capital Partners, LLC have acquired Bellus Medical. Bellus’s non-invasive offerings include the SkinPen, a medical grade microneedling device used exclusively by healthcare professionals to improve the appearance of facial acne scars. It is the f
- Research Identifies Disparities in Outpatient Dermatologic Carehttps://practicaldermatology.com/news/research-identifies-disparities-in-outpatient-dermatologic-care/2457592/The odds of a black or Hispanic patient visiting an outpatient dermatologist are about half that of a white patient with the same skin condition, according to a new study in JAMA Dermatology. Patie
- Candela and Vascular Birthmark Foundation Offer Pro Bono Laser Treatments for Patients in Needhttps://practicaldermatology.com/news/candela-and-vascular-birthmark-foundation-offer-pro-bono-laser-treatments-for-patients-in-need/2457593/Candela Corporation is partnering with the Vascular Birthmarks Foundation (VBF) to provide pro-bono Vbeam laser treatments to children and adults with birthmarks, port wine stains and other vascular related skin conditions as a kickoff to the VBF 18th A
- With Launch of TruSculpt ID, Cutera Defines Today's Body Contouring Patienthttps://practicaldermatology.com/news/with-launch-of-trusculpt-id-cutera-defines-todays-body-contouring-patient/2457594/A third of Americans opt for body sculpting treatments to look better naked, according to a new survey from Cutera, Inc. The survey results were released to coincide with the availability of truSculpt iD, a non-
- Scar-Less Healing May be on the Horizonhttps://practicaldermatology.com/news/scar-less-healing-may-be-on-the-horizon/2457595/Stromal cell-derived-factor-1 (SDF1), a compound secreted in the bloodstream, may be the key factor that causes wounds in older people to heal with less scarring than in younger people, according to researchers from the Perelman School of Medicine at the Univer
- Celebrity Manicurist Joins with Galderma for "Face Your Hands" Campaignhttps://practicaldermatology.com/news/celebrity-manicurist-deborah-lippmann-joins-with-galderma-for-face-your-hands-campaign/2457596/Galderma Laboratories, L.P.,’s Restylane® Lyft is partnering with celebrity manicurist Deborah Lippmann for the "Face Your Hands" campaign, which aims to educate women on the steps they can take to achieve more youthful hands. A
- Nestle to Explore Strategic Options for Skin Health Divisionhttps://practicaldermatology.com/news/nestle-to-explore-strategic-options-for-skin-health-division/2457597/...After further analysis and consideration, the Board has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group’s strategic scope
- FDA Green Lights First Spray-on-Skin Product for Burnshttps://practicaldermatology.com/news/fda-green-lights-first-spray-on-skin-product-for-burns/2457598/The US Food and Drug Administration granted premarket approval to Avita Medical’s Recell, a spray-on-skin that treats second- and third-degree burns in patients aged older than 18 years. The U.S. market launch for the Recell Autologous Cell Harvesting Device (RECELL® System) is